Tag - pharmaceuticals

 
Menu
Search
 
July 16, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
WORLD / Science & Health
Jun 2, 2020
Scientists hunt pandemic hot spots in race to test vaccines
The first wave of the COVID-19 pandemic may be waning. For vaccine developers, that could be a problem.
Japan Times
WORLD / Science & Health
Jun 1, 2020
After fast-tracking Japanese COVID-19 drug, Russia to roll out 'game changer' next week
Russia will start administering its first approved antiviral drug to treat coronavirus patients next week, its state financial backer told Reuters, a move it described as "a game changer" that should speed a return to normal economic life.
Japan Times
BUSINESS / Markets
May 26, 2020
Japan’s AnGes continues surge as coronavirus vaccine candidate moves closer to human trials
The progress of its drug development has led to wild swings in the stock, with shares falling more than 50 percent in two trading sessions earlier this month.
Japan Times
WORLD / Science & Health
May 23, 2020
Gilead’s remdesivir mainly helped healthier COVID-19 patients
Gilead Sciences Inc.’s remdesivir, the first medicine cleared for the treatment of COVID-19, mainly benefited healthier patients who weren’t dependent on ventilators or heart-lung bypass machines, according to published results of the study used to get the medicine on the market.
Japan Times
BUSINESS
May 22, 2020
Fujifilm plans to make flu drug Avigan available for 2 million people by March 2021
Fujifilm Holdings Corp. said Friday it is on course to supply the flu drug Avigan for 2 million COVID-19 patients by next March, meeting a target set by the government to ramp up production of the potential but yet unapproved coronavirus treatment.
Japan Times
JAPAN / Science & Health
May 22, 2020
Japan to subsidize mass production of eventual coronavirus vaccine
More than 110 coronavirus vaccine development projects are underway worldwide, with some in the clinical testing phase, according to a WHO list.
Japan Times
BUSINESS
May 21, 2020
Fukuoka startup to tap RNA tech for inhalable COVID-19 treatment
A biotechnology startup in Fukuoka Prefecture is partnering with local authorities to develop a drug to treat COVID-19 using its RNA technology.
Japan Times
BUSINESS
May 21, 2020
No pause in coronavirus trial for Avigan, Japan's lead researcher says
The lead researcher in the coronavirus trial for flu drug Avigan says it’s too early to make a call on whether it works and shrugged off negative reports about the interim results, saying patients are still being enrolled.
Japan Times
JAPAN / Science & Health
May 20, 2020
Drug Avigan that was pushed by Abe falls short in COVID-19 trials
The lack of results have raised doubts about its approval by the end of this month, as sought by the government.
Japan Times
COMMENTARY / World
May 19, 2020
Vaccine developers need to take their time
Positive study results have arrived quickly, but the next steps will be slower.
Japan Times
WORLD
May 19, 2020
Trump says he’s taking anti-malaria drug that led to FDA warning
Trump is a self-admitted germophobe, telling reporters he was wary of shaking hands even before the coronavirus pandemic.
Japan Times
WORLD / Science & Health
May 14, 2020
France says ‘unacceptable’ for U.S. to get Sanofi vaccine first
Giving the U.S. priority access to a Sanofi vaccine against the new coronavirus would be "unacceptable,” a French government minister said.
Japan Times
BUSINESS
May 14, 2020
Takeda says trial based on blood of recovered virus patients could start in July
Fighting disease with blood from survivors is an ancient strategy that has not been well tested for the novel coronavirus.
Japan Times
JAPAN / Science & Health
May 13, 2020
Japan's health insurance to cover ¥167 million gene therapy drug
Considered the world's most expensive medicine, relatively few cases are expected to require the one-time dosage of drug to treat spinal muscular atrophy.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
Japan Times
JAPAN / FOCUS
May 12, 2020
Abe follows Trump's example, approving drugs quickly after criticism
Japanese regulators are usually known for taking a year to approve new drugs, but authorized remdesivir just three days after receiving the application.
Japan Times
BUSINESS
May 8, 2020
Drugmaker Shionogi rushing to launch coronavirus vaccine in 2021
It is rare to study production before getting the results of clinical trials, but the Japanese drugmaker wants a vaccine on the market as fast as possible.
Japan Times
WORLD / Science & Health
May 2, 2020
U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir
Gilead Science Inc.'s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States.
Japan Times
WORLD / Science & Health
May 1, 2020
Virus drugmaker caught between making a profit and treating the world
Gilead Sciences Inc. may spend $1 billion on its breakthrough new treatment for COVID-19 this year alone, Chief Executive Officer Daniel O’Day said. How much revenue — if any — the company expects to generate is another matter.
Japan Times
JAPAN / Science & Health
Apr 28, 2020
Remdesivir drug to be approved for coronavirus patients in May
This is the first time the government has used the streamlined process since the pandemic started.
Who needs AI when you have Hatsune Miku?
Over the first six months of 2024, a handful of songs using Vocaloid singer Hatsune Miku’s voice have enjoyed widespread attention, underlining a global interest in the character and the technology she represents.
Bloodied Trump survives assassination attempt at political rally
Former U.S. President Donald Trump is surrounded and evacuated by Secret Service agents at a campaign rally in Butler, Pennsylvania, on Saturday. Trump was rushed off stage at the rally after shots rang out.
Shooter came within inches of killing Trump, but left few clues as to why
An aerial view shows the stage where Republican presidential candidate and former U.S. President Donald Trump had been standing during an assassination attempt the day before, and the roof of a nearby building where a gunman was shot dead by law enforcement, in Butler, Pennsylvania, on Sunday.
Yen’s woes seem too big for even a BOJ hike this month to solve
The Bank of Japan headquarters in Tokyo
How to beat Japan’s summer heat in ways better for the planet
Tenugui towels hang up to dry at a dyeing company in Sakai, Osaka Prefecture, on May 8. The durable and versatile tenugui, which many people have in their homes, can be used in many ways to cool one’s body.
The neurological disorder that 'kills culture'
Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
How to beat Japan’s summer heat in ways better for the planet
Tenugui towels hang up to dry at a dyeing company in Sakai, Osaka Prefecture, on May 8. The durable and versatile tenugui, which many people have in their homes, can be used in many ways to cool one’s body.
After Trump shooting, U.S. presidential race might take a violent turn
United States Secret Service Counter Snipers stand guard on a rooftop during a campaign rally for U.S. President Donald Trump in Avoca, Pennsylvania, in 2020.
No AC this summer? No problem (for me).
Think air conditioning is a requirement for a Tokyo summer? Think again.
She’s paying ¥1 million to help behind the scenes at the Paris Olympics
Mai Tarumi, who previously volunteered at the postponed Tokyo Olympics in 2021, has a travel budget of ¥1 million for her trip to volunteer at the Paris Games.

Podcast

You can often see generations of families enjoying performances together at Fuji Rock Festival.
Japan’s summer music festivals are feeling the heat in more ways than one

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'
By Tomoko Otake

SUSTAINABLE JAPAN

Exploring Japanese culturevia Tohoku’s festivals
Exploring Japanese culturevia Tohoku’s festivals

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER